Morphine, Midazolam and Dexmedetomidine in the Management of Acute Cardiogenic Pulmonary Edema, Safety and Efficacy
PHASE1CompletedINTERVENTIONAL
Enrollment
84
Participants
Timeline
Start Date
April 1, 2024
Primary Completion Date
December 1, 2024
Study Completion Date
December 20, 2024
Conditions
Sedative Adverse Reaction
Interventions
DRUG
Injection
dexmedimidine infusion
Trial Locations (1)
Unknown
Menofia university, Shibīn al Kawm
All Listed Sponsors
lead
Menoufia University
OTHER
NCT06653244 - Morphine, Midazolam and Dexmedetomidine in the Management of Acute Cardiogenic Pulmonary Edema, Safety and Efficacy | Biotech Hunter | Biotech Hunter